Alison Bauerlein - 11 Nov 2025 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Role: Chief Operating Officer
Signature: /s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein
Issuer symbol: SGHT
Transactions as of: 11 Nov 2025
Net transactions value: $0
Form type: 4
Filing time: 13 Nov 2025, 16:35:14 UTC
Previous filing: 03 Oct 2025
Next filing: 06 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bauerlein Alison	Chief Operating Officer	C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK	/s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein	13 Nov 2025	0001596080

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SGHT	Common Stock	Award	$0	+23,006	+3.9%	$0.000000	620,526	11 Nov 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing December 31, 2025 and continuing through September 30, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $150,000 of shares of Common Stock as determined by the stock price on the grant date, November 11, 2025. The RSUs have no expiration date.

Content

Reflects a grant of restricted stock units ("RSUs") made to the Reporting Person under the Issuer's 2021 Incentive Award Plan. The RSUs vest in 16 equal quarterly installments commencing December 31, 2025 and continuing through September 30, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.001 per share ("Common Stock"). The number of RSUs granted is equal to approximately $150,000 of shares of Common Stock as determined by the stock price on the grant date, November 11, 2025. The RSUs have no expiration date.